Immunotech Biopharm Ltd (HK:6978) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Immunotech Biopharm Ltd announced that all resolutions proposed at their Annual General Meeting (AGM) on May 24, 2024, were unanimously passed by shareholders. Key resolutions included the adoption of audited financial statements, re-election of board directors, and authorization to issue and repurchase company shares. The approval of these resolutions signals strong shareholder confidence in the company’s leadership and strategic direction.
For further insights into HK:6978 stock, check out TipRanks’ Stock Analysis page.